Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

1.

Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program.

Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R.

Arch Intern Med. 2000 Apr 10;160(7):953-8.

PMID:
10761960
2.

Mammography use, breast cancer stage at diagnosis, and survival among older women.

McCarthy EP, Burns RB, Freund KM, Ash AS, Shwartz M, Marwill SL, Moskowitz MA.

J Am Geriatr Soc. 2000 Oct;48(10):1226-33.

PMID:
11037009
3.

The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.

Duffy SW, Tabar L, Vitak B, Day NE, Smith RA, Chen HH, Yen MF.

Eur J Cancer. 2003 Aug;39(12):1755-60.

PMID:
12888371
4.

Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer.

Gold HT, Do HT, Dick AW.

Cancer. 2008 Dec 1;113(11):3108-15. doi: 10.1002/cncr.23923.

5.

Trends in breast cancer by race and ethnicity: update 2006.

Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M.

CA Cancer J Clin. 2006 May-Jun;56(3):168-83.

6.

Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.

Innos K, Horn-Ross PL.

Breast Cancer Res Treat. 2008 Oct;111(3):531-40. Epub 2007 Nov 4.

PMID:
17978879
7.

Probabilities of death from breast cancer and other causes among female breast cancer patients.

Schairer C, Mink PJ, Carroll L, Devesa SS.

J Natl Cancer Inst. 2004 Sep 1;96(17):1311-21.

PMID:
15339969
8.
9.

Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.

Li CI, Daling JR, Malone KE.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):1008-11.

10.
11.

Risk of recurrence after ductal carcinoma in situ of the breast.

Habel LA, Daling JR, Newcomb PA, Self SG, Porter PL, Stanford JL, Seidel K, Weiss NS.

Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):689-96.

12.

Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years.

Li CI, Moe RE, Daling JR.

Arch Intern Med. 2003 Oct 13;163(18):2149-53.

PMID:
14557212
13.

Breast carcinoma in situ: risk factors and screening patterns.

Claus EB, Stowe M, Carter D.

J Natl Cancer Inst. 2001 Dec 5;93(23):1811-7.

PMID:
11734598
14.
15.

Performance of screening mammography among women with and without a first-degree relative with breast cancer.

Kerlikowske K, Carney PA, Geller B, Mandelson MT, Taplin SH, Malvin K, Ernster V, Urban N, Cutter G, Rosenberg R, Ballard-Barbash R.

Ann Intern Med. 2000 Dec 5;133(11):855-63.

PMID:
11103055
16.

Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.

Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA.

Cancer. 1995 May 15;75(10):2507-17.

17.

Noncancer deaths in white adult cancer patients.

Brown BW, Brauner C, Minnotte MC.

J Natl Cancer Inst. 1993 Jun 16;85(12):979-87.

PMID:
8496983
18.

Effectiveness of radiation therapy in older women with ductal carcinoma in situ.

Smith BD, Haffty BG, Buchholz TA, Smith GL, Galusha DH, Bekelman JE, Gross CP.

J Natl Cancer Inst. 2006 Sep 20;98(18):1302-10.

PMID:
16985249
19.

Breast cancer.

Berg JW, Hutter RV.

Cancer. 1995 Jan 1;75(1 Suppl):257-69.

20.

The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.

Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC.

Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1763-9. doi: 10.1158/1055-9965.EPI-08-1082. Epub 2009 May 19.

Supplemental Content

Support Center